+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
KREBSBIO

Krebs Biochemicals & Industries Share Price

₹57.48 +1.42 (2.53%)
25.20% Fall from 52W High

22 Oct, 2026 3:31 PM (IST)

Krebs Biochemicals & Industries live price: ₹57.48. It opened at ₹57 vs previous close ₹56; intraday high/low: ₹59/₹56. The 50 & 200 DMA stand at ₹57.80/₹60.20.

Krebs Biochemicals & Industries Performance

  • Today's Low
  • ₹56
  • Today's High
  • ₹59
  • 52 Week Low
  • ₹38
  • 52 Week High
  • ₹77
  • Open Price₹57
  • Previous Close₹56
  • Volume3,678
  • 50 DMA₹57.80
  • 100 DMA₹58.00
  • 200 DMA₹60.20

Krebs Biochemicals & Industries Chart

Investment Returns

  • Over 1 Month + 2.24%
  • Over 3 Month + 4.36%
  • Over 6 Month -6.54%
  • Over 1 Year -18.41%

Smart Investing Starts Here Start SIP with Krebs Biochemicals & Industries for Steady Growth!

Invest Now

Krebs Biochemicals & Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -8.8
  • PEG Ratio
  • -0.2
  • Market Cap Cr
  • 124
  • P/B Ratio
  • -0.8
  • Average True Range
  • 4.2
  • EPS
  • -6.5
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.2
  • RSI
  • 48.47
  • MFI
  • 74.71

Latest Stock News Updates

Krebs Biochemicals & Industries Ltd-$ - 524518 - Board Meeting Intimation for Intimation For Board Meeting To Be Held On 29.10.2026.

Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve The Company has enclosed herewith intimation for Board Meeting to be held on 29.10.2026 inter-alia, to consider and adopt the unaudited financial results for the 2nd quarter and half year ended September 30, 2026

Krebs Biochemicals & Industries Ltd-$ - 524518 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

The Company has enclosed herewith certificates recived from RTA under reg 74 (5)

Krebs Biochemicals & Industries Ltd-$ - 524518 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Scrutinizer Report of 34th AGM

Krebs Biochemicals & Industries Financials

Krebs Biochemicals & Industries Technicals

EMA & SMA

Current Price
₹57.48
+ 1.42 (2.53%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹58.40
  • 50 Day
  • ₹57.80
  • 100 Day
  • ₹58.00
  • 200 Day
  • ₹60.20

Resistance and Support

57.59 Pivot Speed
  • R3 61.50
  • R2 60.30
  • R1 58.90
  • S1 56.20
  • S2 54.90
  • S3 53.50

Krebs Biochemicals & Industries Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-29 Quarterly Results
2026-08-06 Quarterly Results
2026-05-21 Audited Results
2026-02-09 Quarterly Results & Others To Consider Other business matters.
2025-11-04 Quarterly Results

Krebs Biochemicals & Industries Shareholding Pattern

72.74%
26.75%
0.5%
0%

About Krebs Biochemicals & Industries

Krebs Biochemicals & Industries is engaged in the business of manufacture of active pharmaceutical ingredients. View More
  • NSE Symbol
  • KREBSBIO
  • BSE Symbol
  • 524518
  • Managing Director,Chief Executive Officer
  • Manish Kumar Jain
  • ISIN
  • INE268B01013

Similar Stocks to Krebs Biochemicals & Industries

Krebs Biochemicals & Industries FAQs

Krebs Biochemicals & Industries share price is ₹57 As on 23 October, 2026 | 02:11

The Market Cap of Krebs Biochemicals & Industries is ₹123.9 Cr As on 23 October, 2026 | 02:11

The P/E ratio of Krebs Biochemicals & Industries is -8.8 As on 23 October, 2026 | 02:11

The PB ratio of Krebs Biochemicals & Industries is -0.8 As on 23 October, 2026 | 02:11

The 52 week High & Low of Krebs Biochemicals & Industries is ₹76.8/₹38.3 respectively As on 23 October, 2026 | 02:11

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23